EUVIMEDEUVIMED entdecken
Open Access

Antifibrotic Effects of Yi‐Qi‐Jian‐Pi‐Xiao‐Yu Formula in Kidney via HIF1A‐Driven M1 Macrophage Polarization

Keda Lu iD, Liqing Ye, Wenze Jiang, Tianyang Cheng, Hong Xia, Peipei Zhang, Bingbing Zhang

Phytochemical Analysis · 2026-08 · 37 (6) · 813-825

DOI: 10.1002/pca.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytochemical Analysis, online erschienen am 10.07.2026. Verfasst von Keda Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Macrophages, Hypoxia-Inducible Factor 1, alpha Subunit, Drugs, Chinese Herbal, Kidney. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Zhejiang province science and technology plan of traditional Chinese medicine in 2020, Modernization Special Project of Zhejiang Province Traditional Chinese Medicine Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A traditional Chinese medicine Yi‐Qi‐Jian‐Pi‐Xiao‐Yu (YQJPXY) formula can potentially ameliorate chronic kidney disease (CKD), but its effect on renal fibrosis (RF), a prevalent pathological feature of CKD, remains unclear.

Methods

To mimic renal injury and fibrosis, a mouse unilateral ureteral obstruction (UUO) model was employed. Using hematoxylin–eosin and Masson's trichrome stains, enzyme‐linked immunosorbent assay, and immunofluorescence, the effects of YQJPXY on renal injury in UUO mice were evaluated. A series of bioinformatics analyses were then conducted to explore the key genes and immune cells involved in the therapeutic mechanism of YQJPXY. Finally, in vivo and in vitro studies provided multifaceted evaluations of YQJPXY against RF from the perspectives of macrophage dynamics and roles of HIF1A.

Results

YQJPXY treatment significantly reduced levels of TGF‐β1 and IL‐6, attenuated tubular damage, decreased extracellular matrix protein (FN and Col‐I) expressions, and modulated fibrosis and epithelial‐mesenchymal transition markers in UUO mice in a dose‐dependent manner. Bioinformatics analysis identified HIF1A as the key target of YQJPXY against RF. In vivo, HIF1A deficiency lessened RF and recruitment of CD45 + CD11b + and CD45 + F4/80 + macrophages in fibrotic kidneys. During treatment, YQJPXY inhibited HIF1A expression and reduced M1 macrophage polarization. In vitro experiments confirmed that YQJPXY suppresses hypoxia‐induced M1 macrophage polarization and HK‐2 cell transdifferentiation via downregulating HIF1A.

Conclusion

YQJPXY alleviates RF by attenuating HIF1A‐mediated M1 macrophage polarization, providing a potential therapeutic approach for CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesHypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalKidneyAnimalsMiceFibrosisMaleUreteral ObstructionMice, Inbred C57BLCell PolarityEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

HIF1AYi‐Qi‐Jian‐Pi‐Xiao‐Yu formulabioinformatic analysismacrophage polarizationrenal fibrosis

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalHif1a protein, mouse

Autor:innen und Institutionen

  • Department of Nephrology, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
  • The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Hangzhou, China.
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.

ORCID-Profile: Keda Lu

Förderung

  • Zhejiang province science and technology plan of traditional Chinese medicine in 2020
  • Modernization Special Project of Zhejiang Province Traditional Chinese Medicine Science and Technology

Zitieren

APA

Lu, K., Ye, L., Jiang, W., Cheng, T., Xia, H., Zhang, P., & Zhang, B. (2026). Antifibrotic Effects of Yi‐Qi‐Jian‐Pi‐Xiao‐Yu Formula in Kidney via HIF1A‐Driven M1 Macrophage Polarization. Phytochemical Analysis, 37(6), 813-825. https://doi.org/10.1002/pca.70077

Vancouver

Lu K, Ye L, Jiang W, Cheng T, Xia H, Zhang P, et al. Antifibrotic Effects of Yi‐Qi‐Jian‐Pi‐Xiao‐Yu Formula in Kidney via HIF1A‐Driven M1 Macrophage Polarization. Phytochemical Analysis. 2026;37(6):813-825. doi:10.1002/pca.70077

BibTeX
@article{Lu2026,
  author = {Lu, Keda and Ye, Liqing and Jiang, Wenze and Cheng, Tianyang and Xia, Hong and Zhang, Peipei and Zhang, Bingbing},
  title = {Antifibrotic Effects of Yi‐Qi‐Jian‐Pi‐Xiao‐Yu Formula in Kidney via HIF1A‐Driven M1 Macrophage Polarization},
  journal = {Phytochemical Analysis},
  year = {2026},
  volume = {37},
  number = {6},
  pages = {813--825},
  doi = {10.1002/pca.70077}
}
Kostenlos starten →